The Japanese Association for Thoracic Surgery has conducted annual surveys of thoracic surgery throughout Japan since 1986 to determine the statistics regarding the number of procedures according to operative category. Here, we have summarized the results from our annual survey of thoracic surgery performed during 2015.
As has been done so far, thoracic surgery was classified into three categories-cardiovascular, general thoracic, and esophageal surgery-and the patient data were examined and analyzed for each group. Access to the computerized data is offered to all members of this Association. We honor and value all member's continued professional support and contributions (Tables 1, 2 ).
The incidence of hospital mortality was added to the survey to determine the nationwide status, which has contributed to the Japanese surgeons to understand the present status of thoracic surgery in Japan and to make progress to improve operative results by comparing their work with those of others. The Association was able to gain a better understanding of present problems as well as future prospects, which has been reflected to its activity including education of its members.
Thirty-day mortality (so-called ''operative mortality'') is defined as death within 30 days of operation regardless of the patient's geographic location and even after the patient had been discharged from the hospital. Hospital mortality is defined as death within any time interval after an operation if the patient had not been discharged from the hospital.
Hospital-to-hospital transfer in the categories of esophageal surgery is not considered discharge: transfer to a nursing home or a rehabilitation unit is considered hospital discharge unless the patient subsequently dies of complications of the operation. On the contrary, hospital-to-hospital transfer after 30 days of operation in the categories of cardiovascular surgery and general thoracic surgery is considered discharge because data of national clinical database (NCD) 2015 were used in this category and hospital-to-hospital transfer after 30 days of operation is considered discharge in NCD.
Abstract of the survey
All data regarding cardiovascular surgery and thoracic surgery were obtained from NCD, whereas data regarding esophageal surgery were collected from survey questionnaire by The Japanese Association for Thoracic Surgery forms because NCD of esophageal surgery does not include non-surgical cases (i.e., patients with adjuvant chemotherapy or radiation alone). Based on the change in data aggregation, there are several differences between this 2015 annual report and previous annual reports: the number of institutions decreased in each category from 578 (2014) to 568 (2015) in cardiovascular, from 762 to 714 in general thoracic and from 626 to 571 in esophageal surgery. Because more than two departments in the same institute registered their data to NCD individually, we cannot calculate correct number of institutes in this survey. Then, the response rate is not indicated in the category of cardiovascular surgery (Table 1) , and the number of institutions classified by the operation number is also not Annual report by The Japanese Association for Thoracic Surgery: Committee for Scientific Affair.
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Extended author information available on the last page of the article calculated in the category of cardiovascular surgery (Table 2 ).
Final report (A) Cardiovascular surgery
First, we are very pleased with our colleague's (member's) cooperation to our survey of cardiovascular surgery, which definitely enhances the quality of this annual report. We are truly grateful again for the enormous effort put into completing the NCD at each participating institution. Figure 1 shows the development of cardiovascular surgery in Japan over the last 29 years. Aneurysm surgery includes only operations for thoracic and thoracoabdominal aortic aneurysm. Extra-anatomic bypass surgery for thoracic aneurysm and pacemaker implantation were totally excluded from the survey since 2015. The number of assist device implantation operations is not included in the total number of surgical operations, while it remained in the survey. A total of 69,512 cardiovascular operations were performed at 561 institutions during 2015 alone and included 44 heart transplantations, which were re-started in 1999.
The number of operations for congenital heart disease (9054 cases) decreased in 2.3% compared with that of 2014 (9269 cases) [1] , and 2.5% decrease when compared with the data of 10 years ago (9287 cases in 2005) [2] . The number of operations for adult heart disease (19,820 cases in valvular heart disease, 15,103 ischemic heart disease, 17,444 cases in thoracic aortic aneurysm and 1897 cases for other procedures) decreased compared with those of 2014 (9.7, 3.4, 0.3 and 10.4%, respectively).
During the last 10 years, the numbers of operations for adult heart disease increased constantly except for that for ischemic heart disease (39.1% increase in valvular heart disease, 23.5% decrease in ischemic heart disease, 101.1% increase in thoracic aortic aneurysm, and 56.5% increase in other procedures compared those of 2005 [2] ). The concomitant coronary artery bypass grafting procedure (CABG) is not included in ischemic heart disease but included in other categories such as valvular heart disease 0   10000   20000   30000   40000   50000   60000   70000   1986  1987  1988  1989  1990  1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011 General Thoracic and Cardiovascular Surgery (2018) 66:581-615 587 Table 3 (continued Table 4 (continued) (b) Off-pump CABG (total 8685)(The present section also includes cases of planned off-pump CABG in which, during surgery, the change is made to an on-pump CABG or on-pump beatingheart procedure) and thoracic aneurysm in our study, then, the number of CABG still remained over 20,000 cases per year (20,785 cases) in 2015. Data for individual categories are summarized in Tables 3, 4 , 5, 6, 7, 8 and 9. In 2015, 6894 open-heart operations for congenital heart disease were performed with overall hospital mortality of 2.7%. The number of operations for congenital heart disease decreased gradually throughout these 10 years (maximum 7386 cases in 2006), and overall hospital mortality showed plateau around 3.0%. In detail, the most common disease was ventricular septal defect (1253 cases), for the first time since the inauguration of this survey. Atrial septal defect (ASD), which had been the most common disease, was the ''second'' common one (1031 cases) in 2015. It was mainly due to the development of catheter device for ASD closure commercially available in Japan since 2005. In the last 10 years, hospital mortality for complex congenital heart disease was as follows (2005 [2] , 2010 [3] , and 2015): complete atrio-septal defect (4.7, 4.2 and 1.7%), tetralogy of Fallot (1.6, 0.8 and 1.3%), transposition of the great arteries with intact septum (6.2, 4.1 and 6.6%) and with ventricular septal defect (15.9, 7.3 and 3.9%), single ventricle (5.3, 7.5 and 4.3%), and hypoplastic left heart syndrome (24.4, 13.1 and 9.8%). Right heart bypass surgery is now commonly performed (364 bidirectional Glenn procedures excluding 48 Damus-Kaye-Stansel procedures and 370 Fontan type procedures including total cavopulmonary connection) with acceptable hospital mortality (1.6 and 2.4%). Norwood type I procedure was performed in 145 cases with relatively low hospital mortality rate of 14.5%.
The number of operations for valvular heart disease has constantly increased until 2014 (21,939 cases) [1] , and that was 19,820 cases in 2015. The hospital mortality of primary single valve placement was 2.8 and 8.7% for the aortic and the mitral position, while that for primary mitral valve repair was 1.7%. Hospital mortality rate for redo valve surgery was 5.7% in aortic and 7.1% in mitral positions, respectively. Finally, overall hospital mortality did not show dramatic improvement during the last 10 years (3.6% in 2005 [2] , 3.1% in 2010 [3] , and 4.0% in 2015), which might be partially due to the recent progression of age of the patients. Repair of the valve became a popular procedure (377 cases in the aortic, 6417 cases in the mitral, and 4942 cases in the tricuspid), and mitral valve repair constituted 32.4% of all valvular operations and 65.0% of all mitral valve procedures, which are similar to those of the last 5 years. Aortic and mitral valve [2] ). Among these, off-pump CABG was intended in 8685 cases (63.0%) with a success rate of 97.2%, so final success rate of off-pump CABG was 61.1%. The percentage of intended off-pump CABG reached 60.3% in 2004 [4] and then was kept over 60% until now. In 13,830 isolated CABG patients, 96.8% of them received at least one arterial graft, while all arterial graft CABGs were performed only in 22.9% of them. The operative and hospital mortality rates associated with primary elective CABG procedures in 11,266 cases were 0.8 and 1.5%, respectively. Similar data analysis of CABG including primary/redo and elective/emergency data was begun in 2003 [5] , and the operative and hospital mortality rates associated with primary elective CABG procedures in 2003 were 1.0 and 1.5%, respectively, so operative results of primary CABG have been stable. Hospital mortality of primary emergency CABG in 2367 cases was still high and was 7.4%. The result of conversion from off-pump CABG rate was 2.8% and hospital mortality in that was 11.3%. A total of 1273 patients underwent surgery for complications of myocardial infarction, including 272 operations for left ventricular aneurysm, ventricular septal perforation or cardiac rupture and 340 operations for ischemic mitral regurgitation.
Operations for arrhythmia were performed mainly as a concomitant procedure in 5765 cases associated with 49.5% increase comparing with that of 2014. The hospital mortality of arrhythmia surgery including 3795 MAZE procedures was 3.1%. MAZE procedure has become quite popular procedure (2497 cases in 2005 [2] and 3591 cases in 2010 [3] ).
Operations for thoracic aortic dissection were performed in 8691 cases and this increased by 12.4% this year compared with those of last year. For 6575 Stanford type A acute aortic dissections, hospital mortality remained high and was 9.9%. Operations for a non-dissected thoracic In summary, the total cardiovascular operations decreased during 2015 by 2933 cases with steadily constant results in almost all categories. The main reason why the number of operations decreased in 2015 was the number of extra-anatomical bypass operations in thoracic aortic aneurysm and the number of trans-venous pacemaker implantations was excluded from the total number of cardiovascular operations in association with the change of data aggregation as was referred to earlier.
(B) General thoracic surgery
The 2015 survey of general thoracic surgery comprised 736 surgical units, and most data were submitted using the webbased collection system of the national clinical database (Fig. 2) . In 2015, 40,302 operations for primary lung cancer were performed (Table 10) , and the number has increased every year. The 2015 value is 2.1 times that of 2001. Operations for lung cancer were 50.5% of all procedures in general thoracic surgery.
The number of video-assisted thoracic surgery (VATS) procedures in the NCD unexpectedly increased in 2014; however, the exact number of such procedures was not published. The increase was attributed to the use of a nonstandard definition of VATS for the NCD registry until 2013. The NCD registry previously included VATS procedures utilizing a skin incision longer than 8 cm and/or a minithoracotomy (hybrid) approach, which are traditionally not regarded as VATS procedures. In this report, the traditional VATS definition is used to describe the number of VATS procedures in the NCD. The number of VATS operations for benign pulmonary tumor, primary lung cancer, and the total number of VATS operation in 2014 and 2015 are shown in Tables 11, 12 There were 2161 operations for benign pulmonary tumors in 2015, which was similar to the number in 2014 (Table 11) . Hamartoma was the most frequent diagnosis in operations for benign pulmonary tumors. VATS was performed in 2063 patients (95.5%). Additional information on primary malignant pulmonary tumors is shown in Tables 12 and 13 . With regard to lung cancer subtype, adenocarcinoma was by far the most frequent diagnosis (70.0% of all lung cancer operations), followed by squamous cell carcinoma (19.0%). Sublobar resection was performed in 10,040 lung cancer cases (24.9% of all cases) and lobectomy was performed in 29,323 cases (72.8% of all cases). Sleeve lobectomy was performed in 541 cases, and pneumonectomy was required in 533 cases (1.3% of all cases). VATS lobectomy for lung cancer was performed in 18,078 cases (61.7%). The number of VATS procedures for primary lung cancer was slightly higher than in 2014.
In total, 129 patients died before hospital discharge within 30 days after lung cancer surgery, and 45 patients died after discharge within 30 days after lung cancer surgery. Therefore, 174 patients died within 30 days after lung cancer surgery (30-day mortality rate, 0.43%). In total, 277 patients died before discharge (hospital mortality rate, 0.69%), and the 30-day mortality rate, by procedure, was 0.26% for segmentectomy, 0.44% for lobectomy, and 2.44% for pneumonectomy. Interstitial pneumonia was the leading cause of death after lung cancer surgery, followed by pneumonia, respiratory failure, and cardiovascular events, as was the case in 2014.
Operations for metastatic pulmonary tumors are shown in Table 14 ; 8226 such operations were performed in 2015, an increase from the previous year. Colorectal cancer was the most frequent diagnosis (47.2% of all cases).
There were 127 operations for malignant tracheal tumor in 2015, but only 16 patients were treated with curative intent (Table 15) .
There were 635 pleural tumors in 2015 (Table 16 ). Diffuse malignant pleural mesothelioma was the most frequent histologic diagnosis. Total pleurectomy was performed in 89 cases and extrapleural pneumonectomy in 80 cases. The hospital mortality rate was 4.5% after total pleurectomy and 5.0% after extrapleural pneumonectomy.
In total, 677 chest wall tumors were resected in 2015 (Table 17) ; 352 (52.0%) were benign. Among the 325 malignant chest wall tumors, 195 (60.0%) were metastatic tumors.
Mediastinal tumors were resected in 4813 patients, a slight increase from the previous year (Table 18) . Thymic epithelial tumor-including 1912 thymomas, 336 thymic carcinomas, and 30 thymic neuroendocrine carcinomaswas the most frequent mediastinal tumor type in 2015.
Thymectomy for myasthenia gravis was performed in 474 cases (Table 19) ; 310 cases were associated with thymoma and the remaining cases were not associated with thymoma. There were 2265 cases of lung resection for inflammatory lung diseases (Table 20) ; 34.2% of the cases were inflammatory tumors of unknown origin, 22.2% were atypical mycobacterium infections, and 13.6% were fungal infections.
The 2739 operations for empyema (Table 21 ) comprised 1999 cases (73.0%) of acute empyema and 740 cases of chronic empyema. Bronchopleural fistula was reported in 466 patients (23.3%) with acute empyema and 325 patients (43.9%) with chronic empyema. The hospital mortality rate was 16.5% in patients with acute empyema with fistula.
There were 98 operations for descending necrotizing mediastinitis (Table 22 ). The hospital mortality rate was 8.2%.
There were 416 operations for bullous diseases (Table 23 ). Lung volume reduction surgery was performed in only 21 patients.
The NCD showed 14,728 operations for spontaneous pneumothorax (Table 24 ). The 11,816 operations for primary pneumothorax comprised 3118 patients (26.4%) who underwent bullectomy only and 7805 patients (66.1%) who underwent an additional procedure. There were 2851 operations for secondary pneumothorax. COPD was by far the most prevalent associated disease (69.5%). The hospital mortality rate for secondary pneumothorax associated with COPD was 3.1%.
The 2015 survey reported 174 operations for chest wall deformity (Table 25) . However, this might be an underestimate, because the Nuss procedure was more likely to have been performed in centers not associated with JATS.
Diaphragmatic hernia was treated surgically in 36 patients (Table 26 ). This figure might be an underestimate, as some procedures might have been classified as gastrointestinal surgery.
The survey reported 388 procedures for chest trauma excluding iatrogenic injuries (Table 27 ). The hospital mortality rate was 6.7%. Table 28 shows operations for other diseases, including 82 cases of arteriovenous malformation and 90 cases of pulmonary sequestration.
A total of 63 lung transplantations were performed in 2015 (Table 29) : 47 patients received lung transplants from brain-dead donors and 16 received transplants from livingrelated donors. The number of lung transplantation procedures has remained constant for several years.
The number of VATS procedures has increased annually, reaching 60,735 in 2015 (Table 30) .
The details of tracheobronchoplasty, pediatric surgery, and combined resection of neighboring organs are shown in Tables 31, 32 , 33 and 34. 
(C) Esophageal surgery
During 2015 alone, a total of 12,732 patients with esophageal diseases were registered from 571 institutions (response rate: 93.6%) affiliated to the Japanese Association for Thoracic Surgery and/or to the Japan Esophageal Society. Among these institutions, those where 20 or more patients underwent esophageal surgeries within the year of 2015 were 136 institutions (23.8%), which shows no definite shift of esophageal operations to high-volume institutions when compared to the data of 2014 (22.1%) (Table 35) . Of 2991 patients with a benign esophageal disease, 1619 (54.1%) patients underwent surgery, and 77 (2.6%) patients underwent endoscopic resection, while 1295 (43.3%) patients did not undergo any surgical treatment (Table 36 ). Of 10,288 patients with a malignant esophageal tumor, 8106 (78.8%) patients underwent resection, esophagectomy for 6151 (59.8%) and endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for 1955 (19.0%), while 2182 (21.2%) patients did not undergo any resection (Tables 37, 38 ). The patients registered, particularly those undergoing non-surgical therapy for a malignant esophageal disease, have been increasing since 1990 (Fig. 3) . Among benign esophageal diseases (Table 36) , hiatal hernia, esophageal varices, esophagitis (including reflux esophagitis) and achalasia were the most common conditions in Japan. On the other hand, spontaneous rupture of the esophagus, benign esophageal tumors and congenital esophageal atresia were common diseases which were surgically treated as well as the above-mentioned diseases. The thoracoscopic and/or laparoscopic procedures have been widely adopted for benign esophageal diseases, in particular achalasia, hiatal hernia and benign tumors. Open (Table 37) . Among esophageal carcinomas, the incidence of squamous cell carcinoma was 90.1%, while that of adenocarcinomas including Barrett cancer was 7.2%. The resection rate for patients with a squamous cell carcinoma was 77.9%, while that for patients with an adenocarcinoma was 88.9%.
According to location, cancer in the thoracic esophagus was the most common (Table 38) . Of the 4137 patients (40.2% of total esophageal malignancies) having superficial esophageal cancers within mucosal and submucosal (Table 38) . Among esophagectomy procedures, transthoracic esophagectomy through right thoracotomy was the most commonly adopted for patients with a superficial cancer as well as for those with an advanced cancer (Table 39) . Transhiatal esophagectomy commonly performed in Western countries was adopted in only 2.8% of patients having cancer, and for 1734 patients (42.0%) with an advanced cancer. The number of cases of thoracoscopic and/or laparoscopic surgery for superficial or advanced cancer has been increasing for these several years (Fig. 4) . Combined resection of the neighboring organs during resection of an esophageal cancer was performed in 351 patients (Tables 39, 40 ). Resection of the aorta together with esophagectomy was performed in three cases.
Tracheal and/or bronchial resection combined with esophagectomy was performed in 15 patients, with the both of 30-day mortality rate and the hospital mortality rate at 0%. Lung resection combined with esophagectomy was performed in 67 patients, with the 30-day mortality rate at 4.5% and the hospital mortality rate at 6.0%.
Salvage surgery after definitive (chemo-)radiotherapy was performed in 264 patients, with the 30-day mortality a Number of patients who underwent the operation b Number of patients died within 30 days after operation c % ratio of b/a, i.e., direct operative mortality rate at 1.5% and with the hospital mortality rate at 8.0% (Table 39) . Lastly, in spite of the efforts of the Committee to cover wider patient populations to this annual survey, the majority of the institutions which responded to the questionnaire were the departments of thoracic or esophageal surgery. It should be noted that larger number of patients with esophageal diseases should have been treated medically and endoscopically. We should continue our effort for complete survey through more active collaboration with the Japan Esophageal Society and other related societies.
